Compare stocks

Alcon Inc. is a global medical company specializing in eye care products. Headquartered in Geneva, Switzerland, Alcon operates in the healthcare industry with a focus on ophthalmology. The company offers a range of products including surgical equipment, contact lenses, and vision care products. Founded in 1945 as a small ophthalmic shop, it has grown to serve a diverse global market with operations across multiple countries. Alcon's strategic positioning leverages its extensive research and development capabilities, allowing it to innovate and adapt within the dynamic field of eye care.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio, while the 2026 acquisition of Apogee adds to AbbVie's immunology depth.